Compare PROF & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | MTRX |
|---|---|---|
| Founded | N/A | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 275.6M |
| IPO Year | 2017 | 1995 |
| Metric | PROF | MTRX |
|---|---|---|
| Price | $5.75 | $9.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $17.00 |
| AVG Volume (30 Days) | 121.3K | ★ 426.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 91.51 |
| EPS | N/A | ★ N/A |
| Revenue | $16,098,000.00 | ★ $873,632,000.00 |
| Revenue This Year | $92.40 | $19.75 |
| Revenue Next Year | $64.10 | $7.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 50.73 | 13.56 |
| 52 Week Low | $4.91 | $9.40 |
| 52 Week High | $8.95 | $15.97 |
| Indicator | PROF | MTRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 27.56 |
| Support Level | $5.78 | N/A |
| Resistance Level | $6.23 | $14.18 |
| Average True Range (ATR) | 0.36 | 0.32 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 22.31 | 3.82 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.